| Primary |
| Gastrooesophageal Reflux Disease |
42.5% |
| Product Used For Unknown Indication |
15.4% |
| Dyspepsia |
6.2% |
| Drug Use For Unknown Indication |
5.7% |
| Barrett's Oesophagus |
4.8% |
| Blood Cholesterol Increased |
2.9% |
| Crohn's Disease |
2.4% |
| Helicobacter Infection |
2.4% |
| Oesophagitis |
2.4% |
| Peptic Ulcer |
1.9% |
| Gastric Ulcer |
1.7% |
| Gastritis |
1.7% |
| Hypertension |
1.7% |
| Asthma |
1.4% |
| Hiatus Hernia |
1.4% |
| Abdominal Pain |
1.2% |
| Convulsion |
1.2% |
| Gastrointestinal Disorder |
1.2% |
| Ulcer |
1.2% |
| Depression |
1.0% |
|
| Vision Blurred |
17.3% |
| Drug Ineffective |
8.2% |
| Nausea |
8.2% |
| Vomiting |
6.4% |
| Weight Decreased |
6.4% |
| Death |
5.5% |
| Diarrhoea |
5.5% |
| Osteonecrosis |
4.5% |
| Product Substitution Issue |
4.5% |
| Urticaria |
4.5% |
| Hip Fracture |
3.6% |
| Hospitalisation |
3.6% |
| Breast Cancer |
2.7% |
| Convulsion |
2.7% |
| Drug Interaction |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Lower Limb Fracture |
2.7% |
| Metabolic Encephalopathy |
2.7% |
| Osteoporosis |
2.7% |
| Pharmaceutical Product Complaint |
2.7% |
|
| Secondary |
| Gastrooesophageal Reflux Disease |
23.5% |
| Product Used For Unknown Indication |
14.9% |
| Drug Use For Unknown Indication |
13.3% |
| Dyspepsia |
8.2% |
| Pain |
6.3% |
| Crohn's Disease |
5.5% |
| Hypertension |
3.5% |
| Depression |
3.4% |
| Foetal Exposure During Pregnancy |
3.3% |
| Gastric Disorder |
2.6% |
| Blood Cholesterol Increased |
1.9% |
| Nausea |
1.8% |
| Abdominal Discomfort |
1.7% |
| Ulcer |
1.6% |
| Irritable Bowel Syndrome |
1.6% |
| Helicobacter Infection |
1.5% |
| Blood Pressure Abnormal |
1.4% |
| Migraine |
1.4% |
| Acute Lymphocytic Leukaemia |
1.3% |
| Arthritis |
1.3% |
|
| Vomiting |
11.5% |
| Drug Ineffective |
9.4% |
| Drug Hypersensitivity |
7.9% |
| Weight Decreased |
7.3% |
| Nausea |
5.2% |
| Somnolence |
5.2% |
| Rash |
4.7% |
| Swelling Face |
4.7% |
| Tremor |
4.7% |
| Drug Dose Omission |
4.2% |
| Overdose |
4.2% |
| Urticaria |
4.2% |
| Vitamin D Deficiency |
4.2% |
| Weight Increased |
4.2% |
| Lethargy |
3.7% |
| Diarrhoea |
3.1% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Malaise |
3.1% |
| Muscle Spasms |
2.6% |
| Pain |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.6% |
| Drug Use For Unknown Indication |
15.7% |
| Gastrooesophageal Reflux Disease |
9.1% |
| Pain |
6.3% |
| Hypertension |
5.7% |
| Depression |
4.8% |
| Rheumatoid Arthritis |
3.4% |
| Asthma |
3.3% |
| Osteoporosis |
3.1% |
| Crohn's Disease |
3.0% |
| Anxiety |
2.8% |
| Diabetes Mellitus |
2.4% |
| Blood Cholesterol Increased |
2.1% |
| Arthritis |
1.8% |
| Insomnia |
1.7% |
| Smoking Cessation Therapy |
1.6% |
| Multiple Myeloma |
1.5% |
| Nausea |
1.4% |
| Prophylaxis |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
|
| Vomiting |
16.7% |
| Weight Decreased |
13.0% |
| Weight Increased |
9.5% |
| Nausea |
6.6% |
| Pain |
5.1% |
| Myocardial Infarction |
4.8% |
| Drug Ineffective |
4.5% |
| Type 2 Diabetes Mellitus |
4.5% |
| Urinary Tract Infection |
3.8% |
| Tremor |
3.5% |
| Vision Blurred |
3.3% |
| Somnolence |
3.1% |
| Pneumonia |
3.0% |
| Rash |
2.9% |
| Pulmonary Embolism |
2.7% |
| Death |
2.7% |
| Pain In Extremity |
2.7% |
| Pruritus |
2.7% |
| Headache |
2.5% |
| Pyrexia |
2.5% |
|
| Interacting |
| Pain |
14.6% |
| Cardiac Disorder |
8.5% |
| Depression |
8.5% |
| Diabetes Mellitus |
8.5% |
| Drug Use For Unknown Indication |
6.7% |
| Nausea |
5.5% |
| Myocardial Infarction |
4.9% |
| Abdominal Discomfort |
4.3% |
| Gastrooesophageal Reflux Disease |
4.3% |
| Post-traumatic Stress Disorder |
4.3% |
| Catatonia |
3.7% |
| Fibromyalgia |
3.7% |
| Insomnia |
3.7% |
| Anxiety |
3.0% |
| Gastric Disorder |
3.0% |
| Seasonal Allergy |
3.0% |
| Smoking Cessation Therapy |
3.0% |
| Hypertension |
2.4% |
| Oesophagitis |
2.4% |
| Constipation |
1.8% |
|
| Weight Decreased |
12.1% |
| Wound |
12.1% |
| Drug Interaction |
9.1% |
| Memory Impairment |
6.1% |
| Myocardial Infarction |
6.1% |
| Pruritus |
6.1% |
| Pulmonary Embolism |
6.1% |
| Retinal Artery Thrombosis |
6.1% |
| Drug Toxicity |
3.0% |
| Dry Mouth |
3.0% |
| Feeling Abnormal |
3.0% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Hallucination |
3.0% |
| Incorrect Drug Administration Duration |
3.0% |
| Musculoskeletal Discomfort |
3.0% |
| Nausea |
3.0% |
| Quality Of Life Decreased |
3.0% |
| Stent Occlusion |
3.0% |
| Therapeutic Response Unexpected |
3.0% |
| Therapy Regimen Changed |
3.0% |
|
